Medical News Today -
27 Dec 2013 18:00
By designing an injectable viral vector that targets blood vessels of tumors, researchers from Washington University School of Medicine in St. Louis, MO, have opened new avenues for gene therapy against cancer and other diseases that have abnormal blood vessels.The achievement is a milestone in the long search for a way of using a deactivated virus to deliver disease-altering genes directly to target cells by injection into the bloodstream.
Share this Article